These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16420219)

  • 1. Advertising the new hypnotics.
    Finucane TE
    J Am Geriatr Soc; 2006 Jan; 54(1):170; author reply 170-2. PubMed ID: 16420219
    [No Abstract]   [Full Text] [Related]  

  • 2. Journals lack explicit policies for separating eds from ads.
    Giles J
    Nature; 2005 Mar; 434(7033):549. PubMed ID: 15800585
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical ethics: funding the discourse.
    Roy N
    Issues Med Ethics; 2002; 10(2):20-1. PubMed ID: 16334924
    [No Abstract]   [Full Text] [Related]  

  • 4. Supplements to medical journals: adding knowledge or subtracting from the public trust?
    Yoshikawa TT; Ouslander JG
    J Am Geriatr Soc; 2006 Jan; 54(1):1-2. PubMed ID: 16420191
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial policy: industry funding and editorial independence.
    MacDonald N; Downie J
    CMAJ; 2006 Jun; 174(13):1817, 1819. PubMed ID: 16785448
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to supplements to medical journals: adding knowledge or subtracting from the public trust?
    Fields D
    J Am Geriatr Soc; 2006 Aug; 54(8):1296; author reply 1296-7. PubMed ID: 16914006
    [No Abstract]   [Full Text] [Related]  

  • 7. Standards for pharmaceutical advertising in Canada.
    Chepesiuk R
    CMAJ; 2005 Aug; 173(3):238; author reply 238. PubMed ID: 16076811
    [No Abstract]   [Full Text] [Related]  

  • 8. [Why this arrogance, Josef Milerad?].
    Olin GA
    Lakartidningen; 2003 Jan; 100(4):254-5. PubMed ID: 12580016
    [No Abstract]   [Full Text] [Related]  

  • 9. [Five direct questions to Josef Milerad concerning credibility].
    Holmgren PG
    Lakartidningen; 2003 Jan; 100(5):346, 349. PubMed ID: 12607383
    [No Abstract]   [Full Text] [Related]  

  • 10. [Shoot the messenger!--or the art of changing the subject of conversation].
    Zackrisson B
    Lakartidningen; 2003 Jan; 100(4):252-3. PubMed ID: 12580015
    [No Abstract]   [Full Text] [Related]  

  • 11. How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag".
    Armstrong D
    Wall St J (East Ed); 2006 May; ():A1, A10. PubMed ID: 16848016
    [No Abstract]   [Full Text] [Related]  

  • 12. [Let the profit from drug advertisement in Lakartidningen go to a research foundation!].
    Järhult B
    Lakartidningen; 2006 Jan 25-31; 103(4):226; discussion 227, 231-3. PubMed ID: 16491557
    [No Abstract]   [Full Text] [Related]  

  • 13. If it's too good to be true, it probably is.
    Kennedy MS
    Am J Nurs; 2009 Dec; 109(12):7. PubMed ID: 19935148
    [No Abstract]   [Full Text] [Related]  

  • 14. [The fight for existence].
    Haug C
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1817. PubMed ID: 12830248
    [No Abstract]   [Full Text] [Related]  

  • 15. Little fish are less likely to take the bait.
    Marcovitch H
    PLoS Med; 2005 Jul; 2(7):e221. PubMed ID: 16033315
    [No Abstract]   [Full Text] [Related]  

  • 16. Focus on the funding and production of evidence rather than its publication.
    Sheldon T
    PLoS Med; 2005 Jul; 2(7):e222. PubMed ID: 16033316
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ghostwriting].
    Haug C
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881
    [No Abstract]   [Full Text] [Related]  

  • 18. Should medical journals carry drug advertising? Yes.
    Smith R
    BMJ; 2007 Jul; 335(7610):74. PubMed ID: 17626959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should medical journals carry drug advertising? No.
    Williams G
    BMJ; 2007 Jul; 335(7610):75. PubMed ID: 17626960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advertising by pharmaceutical companies in eBMJ. The issue should be debated properly.
    McKechnie S
    BMJ; 1999 Feb; 318(7183):598-9. PubMed ID: 10037648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.